NeuroPace (NPCE) Change in Receivables (2020 - 2026)
NeuroPace's (NPCE) quarterly Change in Receivables came in at $108000.0 in Q1 2026, down 95.82% year-on-year from $2.6 million in Q1 2025, and up 142.02% quarter-over-quarter from -$257000.0 in Q4 2025.
NeuroPace (NPCE) Change in Receivables (2020 - 2026) Analysis & Trends
NeuroPace's Change in Receivables history runs 7 years deep, the most recent figure standing at $108000.0 for Q1 2026.
- On a quarterly basis, Change in Receivables fell 95.82% year-over-year to $108000.0 in Q1 2026; TTM through Mar 2026 was -$647000.0, a 117.01% decrease from a year earlier, with the FY2025 full-year figure at $1.8 million, up 241.42% from the prior year.
- Change in Receivables rose to $108000.0 in Q1 2026 per NPCE's latest filing, from -$257000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $2.6 million in Q1 2025 and bottomed at -$1.9 million in Q2 2025.
- The 5-year median for Change in Receivables is $318000.0 (2024), against an average of $453823.5.
- Across the five-year window, Change in Receivables soared 1115.46% in 2022 and sank 383.55% in 2025, its largest moves.
- Year by year, Change in Receivables stood at -$392000.0 in 2022, then soared by 368.37% to $1.1 million in 2023, then gained by 22.53% to $1.3 million in 2024, then slumped by 119.94% to -$257000.0 in 2025, then surged by 142.02% to $108000.0 in 2026.
- Per Business Quant, the three latest NPCE Change in Receivables figures stand at $108000.0 (Q1 2026), -$257000.0 (Q4 2025), and $1.4 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | 108,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,000.00 |
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | -257,000.00 |
| Dec 31, 2025 | -257,000.00 |
| Sep 30, 2025 | 1.38 Mn |
| Sep 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | -1.88 Mn |
| Jun 30, 2025 | -1.88 Mn |
| Mar 31, 2025 | 2.59 Mn |
| Mar 31, 2025 | 2.59 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | 318,000.00 |
| Sep 30, 2024 | 318,000.00 |
| Jun 30, 2024 | -389,000.00 |
| Jun 30, 2024 | -389,000.00 |
| Mar 31, 2024 | -682,000.00 |
| Mar 31, 2024 | -682,000.00 |
| Dec 31, 2023 | 1.05 Mn |
| Dec 31, 2023 | 1.05 Mn |